Infectious Diseases and Clinical Microbiology

Doç. Dr. Zuhal Yeşilbağ

Doctor and researcher Taksim Eğitim ve Araştırma Hastanesi İstanbul
COVID-19HIV InfectionsCross InfectionBacteremiaGram-Negative Bacterial InfectionsHemorrhagic Fever, Crimean
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • COVID-19 7 publications
    Source: OpenAlex / PubMed MeSHView publications
  • HIV Infections 7 publications
  • Cross Infection 3 publications
  • Bacteremia 3 publications
  • Gram-Negative Bacterial Infections 2 publications
  • Hemorrhagic Fever, Crimean 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyInfectious Diseases and Clinical Microbiologysaglik.gov.trFrom source
  • InstitutionTaksim Eğitim ve Araştırma Hastanesisaglik.gov.trFrom source
  • Area of workCOVID-19Extracted from 7 publications · Model version —From source
  • Publications54 publicationsOpenAlex, ORCIDFrom source
  • ORCID0000-0002-7210-1084ORCIDFrom source
  • Last synchronised5 November 2026 08:56https://taksimeah.saglik.gov.tr/TR-809989/doktorlarimiz.html#zuhal-yesilbagsaglik.gov.tr

Scientific work

Publications on COVID-19

54 publications

  1. Tenofovir Disoproxil Fumarate and Entecavir in Patients with Chronic Hepatitis B: Efficacy and Safety Comparison

    Viral Hepatitis Journal, 2026

    DOI 10.4274/vhd.galenos.2026.2025-12-3 Open-access full textSource: OpenAlex

  2. Low 1,25-dihydroxyvitamin D levels are associated with severe COVID-19: an observational study in hospitalized patients

    Frontiers in Nutrition, 2026

    DOI 10.3389/fnut.2026.1836021 PMID 42325512 Open-access full textSource: OpenAlex

  3. HIV-associated FSGS in acute infection: a case report and review of HIVAN and non-collapsing variants

    Future Virology, 2026

    DOI 10.1080/17460794.2026.2649687 Source: ORCID

  4. Candidemia in Türkiye demonstrates nationwide predominance of non-albicans Candida and Candida auris detection

    Scientific Reports, 2026

    DOI 10.1038/s41598-026-53506-3 PMID 42218233 Open-access full textSource: ORCID

  5. Temporal changes in mortality and risk factors of candidemia in intensive care unit patients

    BMC Infectious Diseases, 2026

    DOI 10.1186/s12879-026-13759-9 PMID 42251279 Open-access full textSource: ORCID

  6. Proportion and Characteristics of Primary HIV Infection Among Newly Diagnosed Individuals in Istanbul

    Current HIV Research, 2026

    DOI 10.2174/011570162x507829261004183336 PMID 42872440 Source: ORCID

  7. Clinical and laboratory predictors of mortality in Staphylococcus aureus bacteremia

    Scientific Reports, 2025

    DOI 10.1038/s41598-025-16137-8 PMID 40841738 2 citations (Europe PMC) Open-access full textSource: OpenAlex

  8. Assessing Liver Fibrosis in Chronic Hepatitis B: Liver Biopsy or Non-Invasive Fibrosis Markers?

    Journal of Clinical Medicine, 2025

    DOI 10.3390/jcm14228164 PMID 41303199 2 citations (Europe PMC) Open-access full textSource: OpenAlex

  9. Effects of the COVID-19 pandemic on HIV care in people newly diagnosed with HIV infection

    The Journal of Infection in Developing Countries, 2025

    DOI 10.3855/jidc.20276 PMID 40305529 Open-access full textSource: OpenAlex

  10. Seven-year evaluation of Stenotrophomonas maltophilia bacteremia in a university-affiliated hospital

    The Journal of Infection in Developing Countries, 2025

    DOI 10.3855/jidc.20243 PMID 40305526 7 citations (OpenAlex) Open-access full textSource: OpenAlex

View all 54 publications